Inhibition of selective factor Xa suppresses type 1 diabetes development in mice via the CXCL16 chemokine
Type 1 diabetes mellitus (T1DM) is associated with enhanced thrombosis potential. This research aims to investigate the role of coagulation system activation and CXCL16 in T1DM progression and the possible preventive effect of the selective Factor Xa inhibitor, Fondaparinux (Fond). Forty male Wistar...
Saved in:
| Main Authors: | Mohamed S. Abdel-Bakky, Hamdoon A. Mohammed, Elham Amin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2024-11-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/137797/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemokine CXCL16 Expression Suppresses Migration and Invasiveness and Induces Apoptosis in Breast Cancer Cells
by: Yeying Fang, et al.
Published: (2014-01-01) -
Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans
by: Dolf Segers, et al.
Published: (2011-01-01) -
CXCL16 knockout inhibit asthma airway inflammation by suppressing H2-DM molecular mediated antigen presentation
by: Ting-ting Liu, et al.
Published: (2025-03-01) -
POSSIBILITIES OF INHIBITING ANTICOAGULANT ACTIVITIES THAT INHIBIT XA-FACTOR
by: A. D. Erlich
Published: (2019-06-01) -
Inhibition of nitric oxide synthase activity and chemokine (CXCL12) supplementation can improve hematopoietic reconstitution in mice lethally irradiated by 60Co gamma radiation
by: Daniel Perez Vieira, et al.
Published: (2019-01-01)